Predictive oncology stock.

Charles Nuzum POAI stock SEC Form 4 insiders trading. Charles has made over 1 trades of the Predictive Oncology stock since 2022, according to the Form 4 filled with the SEC. Most recently Charles bought 200,000 units of POAI stock worth $62,000 on 20 May 2022.200,000 units of POAI stock worth $62,000 on 20 May 2022.Mar 9, 2023 · EAGAN, Minn., March 09, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI) , a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities ... Predictive Oncology Inc. analyst ratings, historical stock prices, earnings estimates & actuals. POAI updated stock price target summary.Stock Chart. Data Provided by Refinitiv. Minimum 15 minutes delayed. The Investor Relations website contains information about Predictive Oncology's business for …

Get a real-time Predictive Oncology Inc. (POAI) stock price quote with breaking news, financials, statistics, charts and more.Predictive Oncology (POAI) has 2 splits in our Predictive Oncology stock split history database. The first split for POAI took place on October 29, 2019. This was a 1 for 10 reverse split, meaning for each 10 shares of POAI …

२०२३ मार्च १३ ... $POAI - Predictive Oncology - Extremely Undervalued Growth/AI Biotech Stock? DD. I've recently been looking into various stocks in the oncology ...

View Predictive Oncology Inc POAI investment & stock information. Get the latest Predictive Oncology Inc POAI detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.On average, Predictive Oncology executives and independent directors trade stock every 71 days with the average trade being worth of $99,350. The most recent stock trade was executed by Robert L Myers on 25 September 2023, trading 1,667 units of POAI stock currently worth $5,334.The oncology industry is expected to grow considerably in 2022, driven by the rising occurrence of cancer in the U.S. population. Furthermore, increasing investments by biopharmaceutical companies and the government should fuel the industry's growth. Given the industry's bright growth prospects, Wall Street analysts expect the stocks of …Aug 11, 2022 · An increase of cash and equivalents from $25 million on March 31, 2022, to $28 million at quarter end, which represents a positive change of 12%. Q2 2022 financial results. Predictive Oncology’s ...

Nov 18, 2023 · Predictive Oncology Inc. (NASDAQ:POAI – Get Free Report)’s stock price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $3.98 and traded as low as $3.11. Predictive Oncology shares last traded at $3.11, with a volume of 20,587 shares. Predictive Oncology Price Performance The stock […]

Leading-edge solution. Predictive Oncology has launched a breakthrough solution at a pivotal time in drug discovery that enables pharmaceutical and biotech companies to expedite drug development and speed time to market. The company’s novel platform technology valued at $400M+ has the power to impact a billion-dollar biopharmaceutical ...

Predictive Oncology Inc Stock (POAI) is expected to reach an average price of $47.48 in 2030, with a high forecast of $84.27 and a low forecast of $10.69. This ...Predictive Oncology : If you can look past a reverse stock split, POAI stock is one worth watching. Rekor Systems ( REKR ): The company has a first-mover advantage in a sector that has the ...Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal, and associated products. It operates through the following segments: Helomics, zPREDICTA, Skyline, Soluble, and Corporate.The first of these is Predictive Oncology (NASDAQ: POAI). The company uses a proprietary AI platform to identify drugs that are likely to work against specific tumors. To facilitate this, the ...Predictive Oncology Inc (POAI) Stock Price & News - Google Finance Home POAI • NASDAQ Predictive Oncology Inc Follow Share $2.98 Nov 24, 5:45:00 PM GMT-5 · USD · NASDAQ · Disclaimer search...

Hernandez-Boussard, T., Macklin, P., Greenspan, E.J. et al. Digital twins for predictive oncology will be a paradigm shift for precision cancer care. Nat Med 27, 2065–2066 (2021 ...Apr 20, 2023 · Predictive Oncology (NASDAQ:POAI) on Thursday said it would effect a 1-for-20 reverse stock split.The stock split will become effective on April 24. "The reverse stock split is primarily intended ... Predictive Oncology Pharmaceutical Manufacturing Pittsburgh, PA 1,638 followers Predictive Oncology (NASDAQ:POAI) offers a suite of solutions for oncology drug development from discovery to trials.Predictive Oncology. Price today: US$0.4308. Market cap: US$33.671 million. Predictive Oncology is a company that is focused on the use of data and artificial intelligence to develop personalized cancer therapies, which can lead to more effective treatments and improved patient outcomes.Dec 1, 2023 · Predictive Oncology Inc. (NASDAQ:POAI) issued its quarterly earnings results on Wednesday, August, 11th. The medical instruments supplier reported ($1.00) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.60) by $0.60. The medical instruments supplier had revenue of $0.35 million for the quarter, compared to the ... The Predictive Oncology Inc ( POAI) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $5.0628, representing a +68.20% increase from the current price of $3.01. The highest analyst price target is $9.9664, and the lowest is $0.1593. Based on our technical indicators, the current sentiment ...

Big data and predictive analytics have immense potential to improve risk stratification, particularly in data-rich fields like oncology. This article reviews the literature published on use cases and challenges in applying predictive analytics to improve risk stratification in oncology. We characterized evidence-based use cases of predictive …

When is Predictive Oncology's earnings date? Predictive Oncology has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 19th, 2024 based off last year's report dates. Learn more on POAI's earnings history.Predictive Oncology Inc (POAI) Message Board - Company Name: Predictive Oncology Inc, Stock Symbol: POAI, Industry: Medical - Healthcare - Total Posts: 4357 - Last Post: 07/15/2023 01:24:11 PM - company/specific stock board. Support: 888-992-3836 Home NewsWire SubscriptionsWall Street Stock Market & Finance report, prediction for the future: You'll find the Predictive Oncology share forecasts, stock quote and buy / sell signals below. According to present data Predictive Oncology's POAI shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Helomics, zPREDICTA, Soluble and Skyline. It derives prime revenue from the Skyline segment which consists of the STREAMWAY System product sales, and TumorGenesis subsidiary (Research and Development) is included within corporate. The STREAMWAY System ... The estimated Net Worth of Daniel E Handley is at least $351 Thousand dollars as of 15 December 2022. Daniel Handley owns over 6,000 units of Predictive Oncology stock worth over $350,584 and over the last 3 years he sold POAI stock worth over $0. In addition, he makes $0 as Director at Predictive Oncology.Nov 14, 2023 · Predictive Oncology recorded revenue of $715,056 in the third quarter of 2023, compared to $455,827 for the comparable period in 2022. The increase in revenues related primarily to higher sales of ... For Predictive Oncology stock forecast for 2031, 12 predictions are offered for each month of 2031 with average Predictive Oncology stock forecast of $7.41, a high forecast of $7.95, and a low forecast of $7.1. The average Predictive Oncology stock forecast 2031 represents a 159.26% increase from the last price of $2.85999989509583.David Johnson biography. David O. Johnson is Senior Vice President - Operations of Skyline Medical Inc. He was previously the Acting Chief Operating Officer for the Company since December 2011 and had been a consultant to medical device companies since October 2010.Nov 8, 2023 · Leading-edge solution. Predictive Oncology has launched a breakthrough solution at a pivotal time in drug discovery that enables pharmaceutical and biotech companies to expedite drug development and speed time to market. The company’s novel platform technology valued at $400M+ has the power to impact a billion-dollar biopharmaceutical ...

Real-time quotes, advanced visualizations, historical statements, and much more. Selling, General and Administrative Excl. Other. POAI - Predictive Oncology Inc - Stock screener for investors and traders, financial visualizations.

Predictive Oncology up 13% premarket on coronavirus mention. SA NewsMon, Mar. 02, 2020. Get the latest news and real-time alerts from Predictive Oncology Inc. (POAI) stock at Seeking Alpha.

People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.TipRanks२०२३ मार्च १३ ... $POAI - Predictive Oncology - Extremely Undervalued Growth/AI Biotech Stock? DD. I've recently been looking into various stocks in the oncology ...Nov 8, 2023 · Leading-edge solution. Predictive Oncology has launched a breakthrough solution at a pivotal time in drug discovery that enables pharmaceutical and biotech companies to expedite drug development and speed time to market. The company’s novel platform technology valued at $400M+ has the power to impact a billion-dollar biopharmaceutical ... Shares of Predictive Oncology Inc. (NASDAQ:POAI – Get Free Report) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $3.95 and traded ...December 01, 2021 at 08:31 am EST. EAGAN, Minn., Dec. 01, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology, (POAI), a knowledge-driven company focused on applying artificial intelligence (AI) to develop personalized cancer therapies, today announced the acquisition of zPREDICTA, a company pioneering tumor-specific in vitro 3D cell culture models ...Insiders trading at Predictive Oncology. Over the last 4 years, insiders at Predictive Oncology have traded over $30,944 worth of Predictive Oncology stock and bought 417,770 units worth $148,589 . The most active insiders traders include Carl I. Schwartz, J Melville Engle, and Charles Lee Sr Nuzum.On average, Predictive …An increase of cash and equivalents from $25 million on March 31, 2022, to $28 million at quarter end, which represents a positive change of 12%. Q2 2022 financial results. Predictive Oncology’s ...Information on stock, financials, earnings, subsidiaries, investors, and executives for Predictive Oncology. Use the PitchBook Platform to explore the full ...The estimated Net Worth of Richard L Gabriel is at least $58.5 Thousand dollars as of 1 September 2020. Mr Gabriel owns over 4,000 units of Predictive Oncology stock worth over $56,126 and over the last 6 years he sold POAI stock worth over $0. In addition, he makes $2,333 as Sr. VP of R&D at Predictive Oncology.The all-time high Predictive Oncology stock closing price was 27200.00 on November 09, 2015. The Predictive Oncology 52-week high stock price is 13.88, which is 385.3% above the current share price. The Predictive Oncology 52-week low stock price is 2.47, which is 13.6% below the current share price. The average Predictive Oncology stock price ...

The estimated Net Worth of J Melville Engle is at least $80.3 Thousand dollars as of 24 May 2022. Mr Engle owns over 159,500 units of Predictive Oncology stock worth over $77,289 and over the last 14 years he sold POAI stock worth over $0. In addition, he makes $3,000 as Chairman & CEO at Predictive Oncology.May 16, 2022 · Predictive Oncology Inc. EAGAN, Minn., May 16, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused ... Predictive Oncology (POAI) Gets a Buy Rating from H.C. Wainwright. H.C. Wainwright analyst Vernon Bernardino reiterated a Buy rating on Predictive Oncology (POAI – Research Report) today and set a price target of $5.00. The company's shares closed last Thursday at $1.13. According to TipRanks.com, Bernardino is a 5-star analyst with an ...View Predictive Oncology Inc POAI investment & stock information. Get the latest Predictive Oncology Inc POAI detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Instagram:https://instagram. mortgage without 2 years work historyworkers' comp insurance for self employed costcaltier fund reviewbest sandp 500 index mutual funds Predictive Oncology appoints Bernard A. Harris, Jr., MD, MBA, venture capitalist and former NASA astronaut to serve on the company’s Business… Liked by Bob Myers Some of you know it as ...Nov 18, 2023 · Predictive Oncology Inc. (NASDAQ:POAI – Get Free Report)’s stock price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $3.98 and traded as low as $3.11. Predictive Oncology shares last traded at $3.11, with a volume of 20,587 shares. Predictive Oncology Price Performance The stock […] goog analystqld stock chart Dec 22, 2021 · The upgrade of Predictive Oncology Inc. to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the ... Predictive Oncology appoints Bernard A. Harris, Jr., MD, MBA, venture capitalist and former NASA astronaut to serve on the company’s Business… Liked by Bob Myers Some of you know it as ... c3ai news Bank of America says this under-the-radar oncology stock can rally 180%. Published Fri, Aug 11 202311:35 AM EDT Updated Fri, Aug 11 202312:46 PM EDT. Pia Singh @pia_singh_.Against this backdrop, HLGN stock has carved out a place on watch lists this week. Predictive Oncology Inc. (POAI) There is no shortage of excitement around AI stocks. Thanks to the popularity of ChatGPT, there’s been a surge of interest in any company with exposure to the industry.Insiders trading at Predictive Oncology. Over the last 4 years, insiders at Predictive Oncology have traded over $30,944 worth of Predictive Oncology stock and bought 417,770 units worth $148,589 . The most active insiders traders include Carl I. Schwartz, J Melville Engle, and Charles Lee Sr Nuzum.On average, Predictive …